Roche LDL-Cholesterol Test Recalled for Potential Drug Interference
Roche Diagnostics is recalling 6,255 units of the LDL-Cholesterol plus gen.2. test due to potential false results caused by drug interference.
- Product
- LDL-Cholesterol plus gen.2. The Boehringer Mannheim Direct LDL-Cholesterol test in intended for the quantitative determination of low-density lipoprotein Cholesterol (LDL-C) in serum and plasma.
- Category
- Medical Device
- Distribution
- Distributed nationwide